InspireMD, Inc. (NSPR)
USD 2.69
(3.07%)
USD 2.69
(3.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 22.95 Million USD | 14.44% |
| 2022 | 19.83 Million USD | 28.18% |
| 2021 | 15.47 Million USD | 47.85% |
| 2020 | 10.46 Million USD | -1.03% |
| 2019 | 10.57 Million USD | 22.84% |
| 2018 | 8.6 Million USD | -2.39% |
| 2017 | 8.81 Million USD | 13.77% |
| 2016 | 7.75 Million USD | -41.32% |
| 2015 | 13.2 Million USD | -46.05% |
| 2014 | 24.48 Million USD | 38.61% |
| 2013 | 17.66 Million USD | -11.88% |
| 2012 | 20.04 Million USD | 19.87% |
| 2011 | 16.72 Million USD | 107951.18% |
| 2010 | 15.47 Thousand USD | 304.6% |
| 2009 | 3825.00 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 8.59 Million USD | 11.48% |
| 2024 Q1 | 7.7 Million USD | 22.07% |
| 2023 Q1 | 4.75 Million USD | -7.4% |
| 2023 Q3 | 6.07 Million USD | 4.67% |
| 2023 Q4 | 6.31 Million USD | 3.88% |
| 2023 FY | 22.69 Million USD | 14.44% |
| 2023 Q2 | 5.8 Million USD | 22.13% |
| 2022 Q4 | 5.13 Million USD | 3.18% |
| 2022 Q1 | 4.6 Million USD | 9.07% |
| 2022 FY | 19.83 Million USD | 28.18% |
| 2022 Q2 | 5.11 Million USD | 10.94% |
| 2022 Q3 | 4.97 Million USD | -2.66% |
| 2021 Q2 | 3.7 Million USD | 8.25% |
| 2021 Q4 | 4.22 Million USD | 2.47% |
| 2021 FY | 15.47 Million USD | 47.85% |
| 2021 Q1 | 3.42 Million USD | 2.76% |
| 2021 Q3 | 4.12 Million USD | 11.37% |
| 2020 Q3 | 2.49 Million USD | 7.18% |
| 2020 FY | 10.46 Million USD | -1.03% |
| 2020 Q1 | 2.31 Million USD | -16.24% |
| 2020 Q2 | 2.32 Million USD | 0.43% |
| 2020 Q4 | 3.32 Million USD | 33.49% |
| 2019 Q3 | 2.12 Million USD | -19.05% |
| 2019 Q2 | 2.62 Million USD | -14.13% |
| 2019 Q1 | 3.05 Million USD | 25.65% |
| 2019 FY | 10.57 Million USD | 22.84% |
| 2019 Q4 | 2.76 Million USD | 30.12% |
| 2018 Q2 | 1.75 Million USD | -22.08% |
| 2018 Q4 | 2.43 Million USD | 11.76% |
| 2018 Q3 | 2.17 Million USD | 24.4% |
| 2018 FY | 8.6 Million USD | -2.39% |
| 2018 Q1 | 2.24 Million USD | 35.3% |
| 2017 Q3 | 2.23 Million USD | -8.32% |
| 2017 Q4 | 1.66 Million USD | -25.83% |
| 2017 FY | 8.81 Million USD | 13.77% |
| 2017 Q1 | 2.47 Million USD | 21.59% |
| 2017 Q2 | 2.44 Million USD | -1.49% |
| 2016 Q4 | 2.03 Million USD | 13.16% |
| 2016 FY | 7.75 Million USD | -41.32% |
| 2016 Q1 | 2.45 Million USD | -0.16% |
| 2016 Q3 | 1.8 Million USD | -3.28% |
| 2016 Q2 | 1.86 Million USD | -24.09% |
| 2015 FY | 13.2 Million USD | -46.05% |
| 2015 Q3 | 3.08 Million USD | -7.42% |
| 2015 Q4 | 2.45 Million USD | -20.28% |
| 2015 Q2 | 3.32 Million USD | -23.28% |
| 2015 Q1 | 4.33 Million USD | -10.37% |
| 2014 Q2 | 6.84 Million USD | 7.07% |
| 2014 Q3 | 6.4 Million USD | -6.41% |
| 2014 FY | 24.48 Million USD | 38.61% |
| 2014 Q1 | 6.39 Million USD | 0.0% |
| 2014 Q4 | 4.84 Million USD | -24.42% |
| 2013 Q2 | 4.88 Million USD | 20.54% |
| 2013 Q1 | 4.05 Million USD | -21.63% |
| 2013 FY | 17.66 Million USD | -11.88% |
| 2013 Q4 | - USD | -100.0% |
| 2013 Q3 | 4.68 Million USD | -4.01% |
| 2012 Q2 | 3.25 Million USD | -11.73% |
| 2012 Q1 | 3.69 Million USD | -58.34% |
| 2012 FY | 20.04 Million USD | 19.87% |
| 2012 Q4 | 5.16 Million USD | 45.2% |
| 2012 Q3 | 3.56 Million USD | 9.3% |
| 2011 Q1 | 1.95 Million USD | 75314.26% |
| 2011 FY | 16.72 Million USD | 107951.18% |
| 2011 Q4 | 8.85 Million USD | 165.61% |
| 2011 Q3 | 3.33 Million USD | 29.67% |
| 2011 Q2 | 2.57 Million USD | 31.43% |
| 2010 Q4 | 2595.00 USD | 151.9% |
| 2010 FY | 15.47 Thousand USD | 304.6% |
| 2010 Q3 | -5000.00 USD | -307.04% |
| 2010 Q2 | 2415.00 USD | -36.21% |
| 2010 Q1 | 3786.00 USD | 41.27% |
| 2009 Q1 | 100.00 USD | 0.0% |
| 2009 Q2 | 225.00 USD | 125.0% |
| 2009 Q3 | -6595.00 USD | -3031.11% |
| 2009 FY | 3825.00 USD | 0.0% |
| 2009 Q4 | 2680.00 USD | 140.64% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -104.473% |
| Cerus Corporation | 143.15 Million USD | 83.968% |
| OrthoPediatrics Corp. | 137.01 Million USD | 83.25% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -102.009% |
| Talis Biomedical Corporation | 67.18 Million USD | 65.841% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 8.001% |
| Inogen, Inc. | 236.08 Million USD | 90.279% |
| Spectral AI, Inc. | 20.86 Million USD | -9.998% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 59.016% |
| CVRx, Inc. | 76.14 Million USD | 69.859% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -550.511% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -83.762% |
| Orthofix Medical Inc. | 667.42 Million USD | 96.561% |
| Venus Concept Inc. | 80.47 Million USD | 71.482% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 59.437% |
| Bioventus Inc. | 409.91 Million USD | 94.401% |
| BrainsWay Ltd. | 28.01 Million USD | 18.088% |
| Envoy Medical, Inc. | 17.89 Million USD | -28.227% |
| electroCore, Inc. | 32.03 Million USD | 28.351% |
| IceCure Medical Ltd | 16.87 Million USD | -35.992% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 45.913% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -30.153% |
| MaxCyte, Inc. | 84.84 Million USD | 72.951% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -84.905% |
| Nexalin Technology, Inc. | 5.78 Million USD | -296.966% |
| PAVmed Inc | 64.82 Million USD | 64.598% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 55.069% |
| RxSight, Inc. | 103.85 Million USD | 77.901% |
| Sight Sciences, Inc. | 126.44 Million USD | 81.85% |
| SI-BONE, Inc. | 156.35 Million USD | 85.321% |
| TELA Bio, Inc. | 84.18 Million USD | 72.739% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 67.24% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 88.715% |
| LivaNova PLC | 843.54 Million USD | 97.279% |
| 908 Devices Inc. | 68.08 Million USD | 66.29% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 95.254% |
| Nemaura Medical Inc. | 7.13 Million USD | -221.482% |
| NeuroPace, Inc. | 75.29 Million USD | 69.52% |
| LENSAR, Inc. | 33.33 Million USD | 31.156% |
| Apyx Medical Corporation | 51.01 Million USD | 55.016% |
| Cutera, Inc. | 197.72 Million USD | 88.393% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 7.389% |
| BioSig Technologies, Inc. | 28.53 Million USD | 19.558% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 88.014% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 36.356% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.256% |
| Axonics, Inc. | 270.2 Million USD | 91.506% |
| Outset Medical, Inc. | 198.77 Million USD | 88.454% |
| IRIDEX Corporation | 31.81 Million USD | 27.862% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 87.265% |
| IRadimed Corporation | 30.12 Million USD | 23.812% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -168.987% |
| INVO Bioscience, Inc. | 7.85 Million USD | -192.234% |
| Telesis Bio, Inc. | 63.48 Million USD | 63.852% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 76.689% |
| Varex Imaging Corporation | 224.8 Million USD | 89.791% |
| Quipt Home Medical Corp. | 148.66 Million USD | 84.563% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -95.769% |
| Pulmonx Corporation | 112.68 Million USD | 79.634% |
| Dynatronics Corporation | 9.9 Million USD | -131.63% |
| Modular Medical, Inc. | 17.52 Million USD | -30.926% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -13.687% |
| Semler Scientific, Inc. | 38.94 Million USD | 41.069% |
| InMode Ltd. | 215.68 Million USD | 89.359% |
| Bruker Corporation | 1.07 Billion USD | 97.868% |
| Cytosorbents Corporation | 48.33 Million USD | 52.521% |
| DexCom, Inc. | 1.69 Billion USD | 98.643% |
| Align Technology, Inc. | 2.07 Billion USD | 98.895% |
| Viveve Medical, Inc. | 22.17 Million USD | -3.504% |
| ZimVie Inc. | 275.12 Million USD | 91.658% |
| Movano Inc. | 29.69 Million USD | 22.701% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 83.281% |
| Nexalin Technology, Inc. | 5.78 Million USD | -296.966% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -550.511% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 96.181% |
| Profound Medical Corp. | 33.6 Million USD | 31.703% |
| Insulet Corporation | 939.9 Million USD | 97.558% |
| enVVeno Medical Corporation | 25.23 Million USD | 9.066% |
| Surmodics, Inc. | 98.69 Million USD | 76.747% |
| iCAD, Inc. | 22.22 Million USD | -3.262% |
| Nuwellis, Inc. | 22.61 Million USD | -1.49% |
| Biotricity, Inc. | 17.18 Million USD | -33.55% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 94.853% |
| Aethlon Medical, Inc. | 12.27 Million USD | -86.927% |
| PAVmed Inc. | 64.82 Million USD | 64.598% |
| BIOLASE, Inc. | 34.66 Million USD | 33.787% |
| Beyond Air, Inc. | 61.7 Million USD | 62.804% |
| FONAR Corporation | 28.6 Million USD | 19.768% |
| AxoGen, Inc. | 149.33 Million USD | 84.632% |
| Vivani Medical, Inc. | 26.96 Million USD | 14.89% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 87.041% |
| Inari Medical, Inc. | 448.59 Million USD | 94.884% |
| UFP Technologies, Inc. | 58.08 Million USD | 60.492% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -365.744% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -263.231% |
| Tenon Medical, Inc. | 16.96 Million USD | -35.255% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -210.429% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 47.963% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.871% |
| Sintx Technologies, Inc. | 15.2 Million USD | -50.977% |
| NanoVibronix, Inc. | 4.97 Million USD | -361.492% |
| Quanterix Corporation | 118.1 Million USD | 80.567% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -95.769% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -58.912% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 94.155% |
| TransMedics Group, Inc. | 182.82 Million USD | 87.447% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 18.226% |
| NeuroMetrix, Inc. | 11.09 Million USD | -106.777% |
| Hyperfine, Inc. | 52.87 Million USD | 56.593% |
| Establishment Labs Holdings Inc. | 172 Million USD | 86.657% |
| Biomerica, Inc. | 6.97 Million USD | -228.891% |
| Bone Biologics Corporation | 9.42 Million USD | -143.416% |
| AVITA Medical, Inc. | 80.77 Million USD | 71.589% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -122.573% |
| Silk Road Medical, Inc | 186.35 Million USD | 87.685% |